192 related articles for article (PubMed ID: 32104503)
1. The SIRT2-mediated deacetylation of AKR1C1 is required for suppressing its pro-metastasis function in Non-Small Cell Lung Cancer.
Zhu H; Hu Y; Zeng C; Chang L; Ge F; Wang W; Yan F; Zhao Q; Cao J; Ying M; Gu Y; Zheng L; He Q; Yang B
Theranostics; 2020; 10(5):2188-2200. PubMed ID: 32104503
[TBL] [Abstract][Full Text] [Related]
2. AKR1C1 Activates STAT3 to Promote the Metastasis of Non-Small Cell Lung Cancer.
Zhu H; Chang LL; Yan FJ; Hu Y; Zeng CM; Zhou TY; Yuan T; Ying MD; Cao J; He QJ; Yang B
Theranostics; 2018; 8(3):676-692. PubMed ID: 29344298
[TBL] [Abstract][Full Text] [Related]
3. AKR1C1 alleviates LPS‑induced ALI in mice by activating the JAK2/STAT3 signaling pathway.
Wang X; Yang B; Li Y; Luo J; Wang Y
Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34590152
[TBL] [Abstract][Full Text] [Related]
4. AKR1C1 controls cisplatin-resistance in head and neck squamous cell carcinoma through cross-talk with the STAT1/3 signaling pathway.
Chang WM; Chang YC; Yang YC; Lin SK; Chang PM; Hsiao M
J Exp Clin Cancer Res; 2019 Jun; 38(1):245. PubMed ID: 31182137
[TBL] [Abstract][Full Text] [Related]
5. SIRT2 inhibits non-small cell lung cancer cell growth through impairing Skp2-mediated p27 degradation.
Li Z; Huang J; Yuan H; Chen Z; Luo Q; Lu S
Oncotarget; 2016 Apr; 7(14):18927-39. PubMed ID: 26942878
[TBL] [Abstract][Full Text] [Related]
6. Reversal of inflammation-associated dihydrodiol dehydrogenases (AKR1C1 and AKR1C2) overexpression and drug resistance in nonsmall cell lung cancer cells by wogonin and chrysin.
Wang HW; Lin CP; Chiu JH; Chow KC; Kuo KT; Lin CS; Wang LS
Int J Cancer; 2007 May; 120(9):2019-27. PubMed ID: 17266043
[TBL] [Abstract][Full Text] [Related]
7. Aldo-keto reductase 1C1 induced by interleukin-1β mediates the invasive potential and drug resistance of metastatic bladder cancer cells.
Matsumoto R; Tsuda M; Yoshida K; Tanino M; Kimura T; Nishihara H; Abe T; Shinohara N; Nonomura K; Tanaka S
Sci Rep; 2016 Oct; 6():34625. PubMed ID: 27698389
[TBL] [Abstract][Full Text] [Related]
8. Inhibiting Protein Kinase Activity of Pyruvate Kinase M2 by SIRT2 Deacetylase Attenuates Psoriasis.
Hao L; Park J; Jang HY; Bae EJ; Park BH
J Invest Dermatol; 2021 Feb; 141(2):355-363.e6. PubMed ID: 32679047
[TBL] [Abstract][Full Text] [Related]
9. TPPP3 Promotes Cell Proliferation, Invasion and Tumor Metastasis via STAT3/ Twist1 Pathway in Non-Small-Cell Lung Carcinoma.
Li Y; Bai M; Xu Y; Zhao W; Liu N; Yu J
Cell Physiol Biochem; 2018; 50(5):2004-2016. PubMed ID: 30404076
[TBL] [Abstract][Full Text] [Related]
10. PAI-1/PIAS3/Stat3/miR-34a forms a positive feedback loop to promote EMT-mediated metastasis through Stat3 signaling in Non-small cell lung cancer.
Lin X; Lin BW; Chen XL; Zhang BL; Xiao XJ; Shi JS; Lin JD; Chen X
Biochem Biophys Res Commun; 2017 Dec; 493(4):1464-1470. PubMed ID: 28988111
[TBL] [Abstract][Full Text] [Related]
11. IL-17 induces NSCLC cell migration and invasion by elevating MMP19 gene transcription and expression through the interaction of p300-dependent STAT3-K631 acetylation and its Y705-phosphorylation.
Ge W; Li YA; Ruan Y; Wu N; Ma P; Xu T; Shu Y; Wang Y; Qiu W; Zhao C
Oncol Res; 2024; 32(4):625-641. PubMed ID: 38560562
[TBL] [Abstract][Full Text] [Related]
12. AKR1C1 Contributes to Cervical Cancer Progression via Regulating TWIST1 Expression.
Wei X; Wei Z; Li Y; Tan Z; Lin C
Biochem Genet; 2021 Apr; 59(2):516-530. PubMed ID: 33170398
[TBL] [Abstract][Full Text] [Related]
13. X-ray crystal structure guided discovery of new selective, substrate-mimicking sirtuin 2 inhibitors that exhibit activities against non-small cell lung cancer cells.
Yang LL; Wang HL; Zhong L; Yuan C; Liu SY; Yu ZJ; Liu S; Yan YH; Wu C; Wang Y; Wang Z; Yu Y; Chen Q; Li GB
Eur J Med Chem; 2018 Jul; 155():806-823. PubMed ID: 29957526
[TBL] [Abstract][Full Text] [Related]
14. Structural importance of the C-terminal region in pig aldo-keto reductase family 1 member C1 and their effects on enzymatic activity.
Son M; Park C; Kwon SG; Bang WY; Kim SW; Kim CW; Lee KW
BMC Struct Biol; 2015 Jan; 15():1. PubMed ID: 25583233
[TBL] [Abstract][Full Text] [Related]
15. SIRT2 reduces actin polymerization and cell migration through deacetylation and degradation of HSP90.
Min JS; Kim JC; Kim JA; Kang I; Ahn JK
Biochim Biophys Acta Mol Cell Res; 2018 Sep; 1865(9):1230-1238. PubMed ID: 29908203
[TBL] [Abstract][Full Text] [Related]
16. Promotion of Lung Cancer Metastasis by SIRT2-Mediated Extracellular Protein Deacetylation.
Wu M; Zhang JB; Xiong YW; Zhao YX; Zheng MG; Huang XL; Huang F; Wu XX; Li X; Fan WJ; Hu L; Zeng YY; Cheng XJ; Yue JC; Du JJ; Chen NN; Wei WX; Yao QH; Lu XM; Huang C; Deng J; Chang ZJ; Liu HB; Zhao TC; Chinn YE
Adv Sci (Weinh); 2023 Jan; 10(3):e2205462. PubMed ID: 36453571
[TBL] [Abstract][Full Text] [Related]
17. Inhibitors of human 20α-hydroxysteroid dehydrogenase (AKR1C1).
El-Kabbani O; Dhagat U; Hara A
J Steroid Biochem Mol Biol; 2011 May; 125(1-2):105-11. PubMed ID: 21050889
[TBL] [Abstract][Full Text] [Related]
18. SIRT2 Acts as a Cardioprotective Deacetylase in Pathological Cardiac Hypertrophy.
Tang X; Chen XF; Wang NY; Wang XM; Liang ST; Zheng W; Lu YB; Zhao X; Hao DL; Zhang ZQ; Zou MH; Liu DP; Chen HZ
Circulation; 2017 Nov; 136(21):2051-2067. PubMed ID: 28947430
[TBL] [Abstract][Full Text] [Related]
19. SIRT2 modulates VEGFD-associated lymphangiogenesis by deacetylating EPAS1 in human head and neck cancer.
Hu A; Yang LY; Liang J; Lu D; Zhang JL; Cao FF; Fu JY; Dai WJ; Zhang JF
Mol Carcinog; 2020 Nov; 59(11):1280-1291. PubMed ID: 32965071
[TBL] [Abstract][Full Text] [Related]
20. Natural Product Alantolactone Targeting AKR1C1 Suppresses Cell Proliferation and Metastasis in Non-Small-Cell Lung Cancer.
Fu Z; Li S; Liu J; Zhang C; Jian C; Wang L; Zhang Y; Shi C
Front Pharmacol; 2022; 13():847906. PubMed ID: 35370661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
